Maharashtra FDA cancels Inducare Pharma’s manufacturing licence in Pune
Maharashtra’s FDA has permanently cancelled Pune-based Inducare Pharma’s Ayurvedic drug manufacturing licence after finding GMP and drug-rule violations. Six products were declared substandard, with fungal, microbial and contamination concerns cited.
Maharashtra FDA permanently cancelled Pune-based Inducare Pharma’s Ayurvedic drug manufacturing licence after GMP and drug-rule breaches; six products were declared substandard, citing fungal, microbial and contamination issues.
Why this matters
No prior related signals were provided, making this the first available Inducare Pharma signal in the dataset.
Retail-company signals are accelerating, up 100987% QoQ.